Searching the RRID Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Protocol Name
ClearLab Flu+COVID19 Antigen Assay IFU
DOI:DOI:10.17504/protocols.io.bj8fkrtn RRID Copied  
PDF Report How to cite
petercb3  2020. ClearLab Flu+COVID19 Antigen Assay IFU. protocols.io https://dx.doi.org/10.17504/protocols.io.bj8fkrtn
Copy Citation Copied
Protocol Information

URL: https://dx.doi.org/DOI:10.17504/protocols.io.bj8fkrtn

Authors: petercb3

Group: Coronavirus Method Development Community

Summary: Indication: Qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal aspirate specimens directly or after the aspirate have been added to viral transport media from individuals who are suspected of COVID-19 by their healthcare provider. Emergency use of this test is limited to authorized laboratories and other authorized testing locations.

Affiliations: Chris Baker MD (Aardvark Medical, Inc), Roger Kang (Princeton BioMediTech)

External URL: http://www.clearmynose.com

Version: 1

Publication Date: 2020

Expand All
Usage and Citation Metrics

Coming soon.

Checkfor resource mentions.

Collaborator Network

Coming soon.

Data and Source Information

Source: